Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology ...

Google DeepMind’s Demis Hassabis on his Nobel Prize: ‘It feels like a watershed moment for AI’ The founder of the artificial intelligence R&D lab says scientific understanding can prevent ...

The EU AI Champions Initiative is a group of about 70 financial, technology, and industrial companies that is not an ...

The stunning advance of AlphaFold2, the AI model of structural biology whose creators Demis Hassabis and John Jumper were recognized with the Nobel Prize in chemistry in 2024, is another example. This ...

Google DeepMind CEO and Nobel laureate Demis Hassabis says he would still prioritize STEM subjects if he were a student today, despite artificial intelligence's rapid transformation of the job market.

Joining him onstage recently at Google’s annual developer conference, Demis Hassabis, head of Google’s DeepMind and a recent Nobel Prize winner, agreed.

Dario Amodei, the CEO of the AI company Anthropic, argued last year that the next generation of artificial intelligence will be “smarter than a Nobel Prize winner.” Demis Hassabis, the CEO of Google’s ...

(CNN) — Demis Hassabis, CEO of Google’s AI research arm DeepMind and a Nobel Prize laureate, isn’t too worried about an AI “jobpocalypse.” Instead of fretting over AI replacing jobs, he ...

(CNN) — Demis Hassabis, CEO of Google’s AI research arm DeepMind and a Nobel Prize laureate, isn’t too worried about an AI “jobpocalypse.” Instead of fretting over AI replacing jobs, he’s worried ...

Demis Hassabis, CEO of Google’s AI research arm DeepMind and a Nobel Prize laureate, isn’t too worried about an AI “jobpocalypse.” Instead of fretting over AI replacing jobs, he’s ...